{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T18:28:33Z","timestamp":1769970513030,"version":"3.49.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":1096,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["K23HD091295"],"award-info":[{"award-number":["K23HD091295"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jpainsymman.2022.10.013","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T03:11:44Z","timestamp":1667358704000},"page":"e109-e114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Anticholinergic Medications and Parent-Reported Anticholinergic Symptoms in Neurologically Impaired Children"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3074-8805","authenticated-orcid":false,"given":"James A.","family":"Feinstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5879-0434","authenticated-orcid":false,"given":"Chris","family":"Feudtner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Kempe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1173-2146","authenticated-orcid":false,"given":"Lucas E.","family":"Orth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2022.10.013_bib0001","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-3397","article-title":"Chronic medication use in children insured by medicaid: a multistate retrospective cohort study","volume":"143","author":"Feinstein","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpainsymman.2022.10.013_bib0002","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.22818","article-title":"Complexity of medication regimens for children with neurological impairment","volume":"4","author":"Feinstein","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jpainsymman.2022.10.013_bib0003","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.29082","article-title":"Parent-reported symptoms and medications used among children with severe neurological impairment","volume":"3","author":"Feinstein","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jpainsymman.2022.10.013_bib0004","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1001\/jamapediatrics.2020.2987","article-title":"Identifying important clinical symptoms in children with severe neurological impairment using parent-reported outcomes of symptoms","volume":"174","author":"Feinstein","year":"2020","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jpainsymman.2022.10.013_bib0005","first-page":"62","article-title":"Perceived vs demonstrated understanding of the complex medications of medically complex children","volume":"26","author":"Blackmer","year":"2021","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/j.jpainsymman.2022.10.013_bib0006","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1542\/peds.2014-2015","article-title":"Potential drug-drug interactions in infant, child, and adolescent patients in children's hospitals","volume":"135","author":"Feinstein","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpainsymman.2022.10.013_bib0007","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/pds.3843","article-title":"The depth, duration, and degree of outpatient pediatric polypharmacy in Colorado fee-for-service Medicaid patients","volume":"24","author":"Feinstein","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jpainsymman.2022.10.013_bib0008","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12877-015-0029-9","article-title":"Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review","volume":"15","author":"Salahudeen","year":"2015","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jpainsymman.2022.10.013_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219598","article-title":"Increased expression of blood muscarinic receptors in patients with reflex syncope","volume":"14","author":"Beutelstetter","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jpainsymman.2022.10.013_bib0010","doi-asserted-by":"crossref","unstructured":"Hilmer SN, Mager DE, Simonsick EM, et al. A drug burden index to define the functional burden of medications in older people. Archives of internal medicine. 2007;167:781-7. Epub 2007\/04\/25.https:\/\/doi.org\/10.1001\/archinte.167.8.781. PubMed PMID: 17452540.","DOI":"10.1001\/archinte.167.8.781"},{"key":"10.1016\/j.jpainsymman.2022.10.013_bib0011","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/jamapediatrics.2018.0256","article-title":"R package for pediatric complex chronic condition classification","volume":"172","author":"Feinstein","year":"2018","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jpainsymman.2022.10.013_bib0012","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/jamapediatrics.2019.2672","article-title":"Identification of children with high-intensity neurological impairment","volume":"173","author":"Thomson","year":"2019","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jpainsymman.2022.10.013_bib0013","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-009217","article-title":"Timing of Co-occurring chronic conditions in children with neurologic impairment","volume":"147","author":"Thomson","year":"2021","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpainsymman.2022.10.013_bib0014","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jpainsymman.2022.10.013_bib0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020554","article-title":"Risk factors associated with paediatric unplanned hospital readmissions: a systematic review","volume":"9","author":"Zhou","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jpainsymman.2022.10.013_bib0016","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/pch\/pxy188","article-title":"Choosing medications wisely: Is it time to address paediatric polypharmacy?","volume":"24","author":"Bogler","year":"2019","journal-title":"Paediatr Child Health"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392422009526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392422009526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T03:50:38Z","timestamp":1769917838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392422009526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0885392422009526"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2022.10.013","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticholinergic Medications and Parent-Reported Anticholinergic Symptoms in Neurologically Impaired Children","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2022.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}